European Journal of Medicinal Chemistry p. 321 - 326 (1995)
Update date:2022-09-26
Topics:
Komiotis, D.
Pananookooln, S.
Zaw, K.
Dieter, J. P.
Breton, G. C. Le
Venton, D. L.
The title compounds have been synthesized and their in vitro thromboxane A2(TxA2) receptor antagonist activity evaluated.Both cis and trans isomers (1,2) were shown to specifically inhibit submaximal human platelet aggregation induced by 225 nM U46619 in a dose-dependent manner with an IC50 of 1 μM.The concentration of 1 and 2 required to completely block maximal aggregation induced by 3 μM U46619 was 3 μM. thromboxane A2/ receptor antagonist/ platelet aggregation/ 1,3-dioxolane
View MoreContact:+86-511-88790000
Address:338 North Yushan Rd, Zhenjiang, Jiangsu 212016
Contact:86 311 85902108 / 85902109
Address:room 1001-1005 ,huanghe Road ,shijiazhuang ,China
Landz International Company Ltd.
Contact:0086-21-58891610
Address:985 Dongfang Road, Pudong, Shanghai 200122 China
Triumph International Development Limilted
website:http://www.jiashengchem.cn/
Contact:+86-536-7971999
Address:Yinhai Road,Shouguang
Taixing Shenfeng Chemical Co., Ltd.
Contact:+86-523-87117033, 87117666
Address:4# Yinsanlu, Huangqiao town, Taixing, Jiangsu, China.
Doi:10.1016/S0040-4039(00)85246-6
(1986)Doi:10.1039/c39900000897
(1990)Doi:10.1039/c2ob06934b
(2012)Doi:10.1007/BF00487436
(1990)Doi:10.1021/ol2011067
(2011)Doi:10.1016/0022-328X(86)82021-6
(1986)
